Holick MF: Vitamin D: Importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr. 2004, 79: 362-371.
CAS
PubMed
Google Scholar
Chiu K, Chu A, Go V, Soad M: Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr. 2004, 79: 820-825.
CAS
PubMed
Google Scholar
Pittas AG, Dawson-Hughes B, Li T, Van Dam RM, Willett WC, Manson JE, Hu FB: Vitamin D and calcium intake in relation to type 2 diabetes in women. Diabetes Care. 2006, 29: 650-656.
Article
CAS
PubMed
Google Scholar
Forman JP, Giovannucci E, Holmes MD, Bischoff-Ferrari HA, Tworoger SS, Willett WC, Curhan GC: Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension. 2007, 49: 1063-1069.
Article
CAS
PubMed
Google Scholar
Wang TJ, Pencina MJ, Booth SL, Jacques PF, Ingelsson E, Lanier K, Benjamin EJ, D'Agostino RB, Wolf M, Vasan RS: Vitamin D deficiency and risk of cardiovascular disease. Circulation. 2008, 117: 503-511.
Article
CAS
PubMed
Google Scholar
Zittermann A, Schleithoff SS, Koerfer R: Putting cardiovascular disease and vitamin D insufficiency into perspective. Br J Nutr. 2005, 94: 483-492.
Article
CAS
PubMed
Google Scholar
Zittermann A, Schleithoff SS, Tenderich G, Berthold HK, Körfer R, Stehle P: Low vitamin D status: a contributing factor in the pathogenesis of congestive heart failure?. J Am Coll Cardiol. 2003, 41: 105-112.
Article
CAS
PubMed
Google Scholar
Dobnig H, Pilz S, Scharnagl H, Renner W, Seelhorst U, Wellnitz B, Kinkeldei J, Boehm BO, Weihrauch G, Maerz W: Independent association of low serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality. Arch Intern Med. 2008, 168: 1340-1349.
Article
CAS
PubMed
Google Scholar
Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP: 1,25-dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest. 2002, 110: 229-238.
Article
CAS
PubMed
PubMed Central
Google Scholar
Xiang W, Kong J, Chen S, Cao LP, Qiao G, Zheng W, Liu W, Li X, Gardner DG, Li YC: Cardiac hypertrophy in vitamin D receptor knockout mice: role of the systemic and cardiac renin-angiotensin systems. Am J Physiol Endocrinol Metab. 2005, 288 (1): E125-E132.
Article
CAS
PubMed
Google Scholar
Li YC: Vitamin D and the renin-angiotensin system. Vitamin D. Edited by: Feldman D, Pike JW, Glorieux FH. 2005, London, Elsevier, 871-881. 2
Chapter
Google Scholar
Perkovic V, Hewitson TD, Kelynack KJ, Martic M, Tait MG, Becker GJ: Parathyroid hormone has a prosclerotic effect on vascular smooth muscle cells. Kidney Blood Press Res. 2003, 26: 27-33.
Article
CAS
PubMed
Google Scholar
Bidmon H-J, Gutkowska J, Murakami R, Stumpf WE: Vitamin D receptors in heart: effects on atrial natriuretic factor. Experientia. 1991, 47: 958-962.
Article
CAS
PubMed
Google Scholar
Saadi HF, Dawodu A, Afandi BO, Zayed R, Benedict S, Nagelkerke N: Efficacy of daily and monthly high-dose calciferol in vitamin D deficient nulliparous and lactating women. Am J Clin Nutr. 2007, 85: 1565-1571.
CAS
PubMed
Google Scholar
Saadi HF, Nagelkerke N, Benedict S, Qazaq HS, Zilahi E, Mohamadiyeh MK, Al-Suhaili AI: Predictors and relationships of serum 25 hydroxyvitamin D concentration with bone turnover markers, bone mineral density, and vitamin D receptor genotype in Emirati women. Bone. 2006, 39: 1136-1143.
Article
CAS
PubMed
Google Scholar
Saadi H, Kazzam E, Ghurbana BA, Nicholls MG: Hypothesis: correction of low vitamin D status among Arab women will prevent heart failure and improve cardiac function in established heart failure. Eur J Heart Fail. 2006, 8: 694-696.
Article
CAS
PubMed
Google Scholar
Richards AM, Doughty R, Nicholls MG, MacMahon S, Sharpe N, Murphy J, Espiner EA, Frampton C, Yandle TG, Australia-New Zealand Heart Failure Group: Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: prognostic utility and prediction of benefit from carvedilol in chronic ischemic left ventricular dysfunction. J Am Coll Cardiol. 2001, 37: 1781-1787.
Article
CAS
PubMed
Google Scholar
Hunt PJ, Richards AM, Nicholls MG, Yandle TG, Doughty RN, Espiner EA: Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-PROBNP): a new marker of cardiac impairment. Clin Endocrinol (Oxf). 1997, 47 (3): 287-296.
Article
CAS
Google Scholar
Obineche EN, Saadi H, Benedict S, Pathan JY, Frampton CM, Nicholls MG: Inter-relationships between B-type natriuretic peptides and Vitamin D in patients on maintenance peritoneal dialysis. Peritoneal Dialysis International. 2008, 28: 617-621.
CAS
PubMed
Google Scholar
Zittermann A, Schleithoff SS, Götting C, Dronow O, Fuchs U, Kuhn J, Kleesiek K, Tenderich G, Koerfer R: Poor outcome in end-stage heart failure patients with low circulating calcitriol levels. Eur J Heart Fail. 2008, 10: 321-327.
Article
CAS
PubMed
Google Scholar
Schleithoff SS, Zittermann A, Tenderich G, Berthold HK, Stehle P, Koerfer R: Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial. Am J Clin Nutr. 2006, 83: 754-759.
CAS
PubMed
Google Scholar
Park CW, Oh YS, Shin YS, Kim CM, Kim YS, Kim SY, Choi EJ, Chang YS, Bang BK: Intravenous calcitriol regresses myocardial hypertrophy in hemodialysis patients with secondary hyperparathyroidism. Am J Kidney Dis. 1999, 33: 73-81.
Article
CAS
PubMed
Google Scholar
Kim HW, Park CW, Shin YS, Kim YS, Shin SJ, Kim YS, Choi EJ, Chang YS, Bang BK: Calcitriol regresses cardiac hypertrophy and QT dispersion in secondary hyperparathyroidism on hemodialysis. Nephron. 2006, 102: c21-29.
PubMed
Google Scholar
Whittaker PG, Macphail S, Lind T: Serial hematologic changes and pregnancy outcome. Obstet Gynecol. 1996, 88: 33-39.
Article
CAS
PubMed
Google Scholar
The puerperium. Williams Obstetrics. Edited by: Cunningham FG, Gant NF, Leveno KJ, Gilstrap LC, Hauth JC, Wenstrom KD. 2001, New York, McGraw-Hill, 403-422. 21
Lev-Sagie A, Bar-Oz B, Salpeter L, Hochner-Celnikier D, Arad I, Nir A: Plasma concentrations of N-terminal Pro-B-Type natriuretic peptide in pregnant women near labor and during early puerperium. Clin Chem. 2005, 51: 1909-1910.
Article
CAS
PubMed
Google Scholar
Dawodu A, Absood G, Patel M, Agarwal M, Ezimokhai M, Abdulrazzaq Y, Khalayli G: Biosocial factors affecting vitamin D status of women of child-bearing age in the United Arab Emirates. J Biosoc Sci. 1998, 30: 431-437.
Article
CAS
PubMed
Google Scholar
Cooper L, Clifton-Bligh PB, Nery ML, Figtree G, Twigg S, Hibbert E, Robinson BG: Vitamin D supplementation and bone mineral density in early postmenopausal women. Am J Clin Nutr. 2003, 77: 1324-1329.
CAS
PubMed
Google Scholar
Veith R: The pharmacology of vitamin D, including fortification strategies. Vitamin D. Edited by: Feldman D, Pike JW, Glorieux FH. 2005, London, Elsevier, 995-1015. 2
Chapter
Google Scholar
Barger-Lux MJ, Heaney RP, Dowell S, Chen TC, Holick MF: Vitamin D and its major metabolites: serum levels after graded oral dosing in healthy men. Osteoporos Int. 1998, 8: 222-230.
Article
CAS
PubMed
Google Scholar
Heaney RP, Davies KM, Chen TC, Holick MF, Barger-Lux MJ: Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr. 2003, 77: 204-210.
CAS
PubMed
Google Scholar
Trang HM, Cole DE, Rubin LA, Pierratos A, Siu S, Vieth R: Evidence that vitamin D3 increases serum 25-hydroxyvitamin D more efficiently than does vitamin D2. Am J Clin Nutr. 1998, 68: 854-858.
CAS
PubMed
Google Scholar
Armas LA, Hollis BW, Heaney RP: Vitamin D2 is much less effective than vitamin D3 in humans. J Clin Endocrinol Metab. 2004, 89: 5387-5391.
Article
CAS
PubMed
Google Scholar
Holick MF, Biancuzzo RM, Chen TC, Klein EK, Young A, Bibuld D, Reitz R, Salameh W, Ameri A, Tannenbaum AD: Vitamin D2 is as effective as vitamin D3 in maintaining circulating concentrations of 25-hydroxyvitamin D. J Clin Endocrinol Metab. 2008, 93: 677-681.
Article
CAS
PubMed
Google Scholar